Ignite Creation Date:
2024-05-05 @ 11:43 PM
Last Modification Date:
2024-10-26 @ 10:39 AM
Study NCT ID:
NCT01407822
Status:
UNKNOWN
Last Update Posted:
2018-09-11
First Post:
2011-07-26
Brief Title:
Erlotinib Versus GemcitabineCisplatin as NeoAdjuvant Treatment in Non-small Cell Lung Cancer
Sponsor:
Guangdong Association of Clinical Trials
Organization:
Guangdong Association of Clinical Trials
Organization Data
Organization:
Guangdong Association of Clinical Trials
Class:
OTHER
Study ID:
CTONG 1103
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Guangdong Association of Clinical Trials
Lead Sponsor Class:
OTHER
Responsible Party:
Yi-Long Wu
Responsible Party Title:
Dr
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Guangdong Association of Clinical Trials
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Northern Jiangsu Peoples Hospital | OTHER |
| Guangdong Provincial Peoples Hospital | OTHER |
| Tianjin Medical University Cancer Institute and Hospital | OTHER |
| Jilin Provincial Tumor Hospital | OTHER |
| Jiangsu Cancer Institute Hospital | OTHER |
| Zhejiang Cancer Hospital | OTHER |
| Peking University Cancer Hospital Institute | OTHER |
| Sun Yat-sen University | OTHER |
| West China Hospital | OTHER |
| The First Affiliated Hospital of Dalian Medical University | OTHER |
| Peking University Peoples Hospital | OTHER |
| Health Science Center of Xian Jiaotong University | OTHER |
| Shanghai Zhongshan Hospital | OTHER |
| Guangzhou General Hospital of Guangzhou Military Command | OTHER |
| The First Affiliated Hospital of Guangzhou Medical University | OTHER |
| Fujian Medical University Union Hospital | OTHER |
| Linyi Tumour Hospital | OTHER |